Adam Tepper

Adam Tepper currently serves as the Corporate Controller at Natural Alternatives International, Inc., overseeing financial planning and analysis, accounting, and SEC reporting for a publicly traded global pharmaceutical manufacturer. Prior experience includes leading global finance and accounting at Biotix and holding senior financial roles at Alphatec Spine and One Industries, where responsibilities encompassed strategic financial planning and performance improvement. Tepper also held significant finance positions at Thermo Fisher Scientific, managing full P&L and influencing strategic planning, as well as finance management roles at Kashi and PricewaterhouseCoopers, focusing on audit engagements and finance operations. Tepper holds a B.S. in Accounting from San Diego State University.